Evofem Biosciences Current Cash

Evofem Biosciences (EVFM) currently reports a current cash of $290K as of June 2026. That compares with $750K in the prior-year period — down 61.9% year over year. Use the charts on this page to explore Evofem Biosciences's current cash history and peer comparisons.

Evofem Biosciences's current cash decreased from $750K to $290K — a 61.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evofem Biosciences reported $290K in current cash as of June 2026. That compares with $750K in the prior-year period — down 61.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $290K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evofem Biosciences, and consider following EVFM for alerts when major investors trade the stock.

Evofem Biosciences is classified in the Healthcare sector. On current cash, it currently shows $290K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVFM with unrelated industries.